Published in Clin Microbiol Infect on November 01, 2004
High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol (2009) 1.99
Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci U S A (2006) 1.98
Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev (1993) 9.38
Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother (2001) 3.87
Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. Antimicrob Agents Chemother (1976) 3.26
THE EFFECT OF CAFFEIN SODIO-BENZOATE, THEO-BROMIN SODIO-SALICYLATE, THEOPHYLLIN AND EUPHYLLIN ON THE CORONARY FLOW AND CARDIAC ACTION OF THE RABBIT. J Clin Invest (1925) 2.89
Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob Agents Chemother (1985) 2.66
The life expectancy of nonsmoking men and women. Public Health Rep (1983) 2.34
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida. Antimicrob Agents Chemother (2000) 2.33
Enzymatic modification of aminoglycoside antibiotics: a new 3-N-acetylating enzyme from a Pseudomonas aeruginosa isolate. Antimicrob Agents Chemother (1976) 2.10
Isolation, characterization, and DNA sequence analysis of an AAC(6')-II gene from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1989) 2.08
Characterization of the chromosomal aac(6')-Ic gene from Serratia marcescens. Antimicrob Agents Chemother (1992) 1.97
Dating pleistocene archeological sites by protein diagenesis in ostrich eggshell. Science (1990) 1.76
Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys. Antimicrob Agents Chemother (2000) 1.64
Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6'-N-acetyltransferase Ib and IIa proteins. J Bacteriol (1992) 1.64
Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrob Agents Chemother (1991) 1.62
Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside. Antimicrob Agents Chemother (1978) 1.61
Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens. Antimicrob Agents Chemother (1990) 1.59
Cancer, passive smoking and nonemployed and employed wives. West J Med (1984) 1.59
Renal pharmacology of netilmicin. Antimicrob Agents Chemother (1977) 1.29
Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J Infect Dis (2000) 1.27
Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo. Antimicrob Agents Chemother (1987) 1.26
Surface-active substrates for Raman and luminescence analysis. Talanta (2008) 1.20
Sulfonamide structure-activity relationships in a cell-free system. 2. Proof for the formation of a sulfonamide-containing folate analog. J Med Chem (1974) 1.15
Kinetics and mechanisms of action of antibiotics on microorganisms. V. Chloramphenicol and tetracycline affected Escherichia coli generation rates. J Pharm Sci (1966) 1.15
Biological activity of SCH 21420, the 1-N-S-alpha-hydroxy-beta-aminopropionyl derivative of gentamicin B. J Antibiot (Tokyo) (1978) 1.13
The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin Microbiol Infect (2001) 1.12
The syntheses and biological properties of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B. J Antibiot (Tokyo) (1978) 1.10
Chemical modification of everninomicins. J Antibiot (Tokyo) (1982) 1.10
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304. Antimicrob Agents Chemother (1992) 1.08
Aminoglycoside resistance genes aph(2")-Ib and aac(6')-Im detected together in strains of both Escherichia coli and Enterococcus faecium. Antimicrob Agents Chemother (2001) 1.07
Cloning and characterization of a 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ib, from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.07
The Ledermann model of alcohol consumption. Description, implications and assessment. Q J Stud Alcohol (1974) 1.06
Cloning and DNA sequence analysis of an aac(3)-Vb gene from Serratia marcescens. Antimicrob Agents Chemother (1992) 1.02
Lactation and genital involution effects of a new low-dose oral contraceptive on breast-feeding mothers and their infants. Obstet Gynecol (1970) 1.01
Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343. J Antimicrob Chemother (1985) 1.01
Kinetics and mechanisms of action of trimethoprim and sulfonamides, alone or in combination, upon Escherichia coli. Chemotherapy (1972) 1.01
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice. Antimicrob Agents Chemother (1992) 1.00
Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance). J Antimicrob Chemother (1990) 0.99
Pulmonary hemorrhage and glomerulonephritis. Treatment of two cases by bilateral nephrectomy and renal transplantation. Arch Surg (1968) 0.99
Sulfonamide structure-activity relationship in a cell-free system. Correlation of inhibition of folate synthesis with antibacterial activity and physicochemical parameters. J Med Chem (1972) 0.98
Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides. J Clin Microbiol (1992) 0.96
Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa. J Clin Microbiol (1984) 0.96
Nucleotide sequence analysis and DNA hybridization studies of the ant(4')-IIa gene from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1993) 0.95
Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. Farmaco (2001) 0.93
Male-female longevity comparisons among the Amish. J Indiana State Med Assoc (1980) 0.93
Others would get similar longevity results if they took greater care. Public Health Rep (1984) 0.92
The application of molecular techniques for the study of aminoglycoside resistance. Methods Mol Med (1998) 0.92
Psychiatric manpower in Ontario. Part I: A survey and recommendations. Can J Psychiatry (1982) 0.92
Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Diagn Microbiol Infect Dis (1995) 0.91
Interspecies pharmacokinetic scaling of Sch 34343. J Antimicrob Chemother (1985) 0.91
Evaluation of the in-vitro activity of Sch 29482. J Antimicrob Chemother (1982) 0.91
Bacterial enzymatic resistance: beta-lactamases and aminoglycoside-modifying enzymes. Curr Opin Microbiol (1998) 0.90
Lung cancer: a comparison of incidence between the Amish and non-Amish in Lancaster County. J Indiana State Med Assoc (1983) 0.90
Activity of (+)-cyclaradine (Sch 31172) against herpes simplex virus in vitro and in vivo. Antimicrob Agents Chemother (1987) 0.89
Intracellular measurements in mammary carcinoma cells using fiber-optic nanosensors. Anal Biochem (2000) 0.89
Analysis of the aac(3)-VIa gene encoding a novel 3-N-acetyltransferase. Antimicrob Agents Chemother (1993) 0.89
Evaluation of the in-vitro antibacterial activity of Sch 34343. J Antimicrob Chemother (1985) 0.87
A model for predicting utilization of psychiatric facilities. Can J Psychiatry (1986) 0.87
Netilmicin disk susceptibility tests: effect of cations on the MIC correlates. Eur J Clin Microbiol (1987) 0.86
The hazimicins, a new class of antibiotics. Taxonomy, fermentation, isolation, characterization and biological properties. J Antibiot (Tokyo) (1983) 0.86
Experimental shock chemistry of aqueous amino acid solutions and the cometary delivery of prebiotic compounds. Orig Life Evol Biosph (2001) 0.86
Renal uptake and nephrotoxicity of gentamicin during urinary alkalinization in rats. Clin Exp Pharmacol Physiol (1979) 0.85
Quantification of the antibacterial action of trimethoprim alone and in combination with sulfonamides by bacterial growth kinetics. J Infect Dis (1973) 0.84
Sch 29482, a new penem antibiotic: evaluation of in-vitro activity and effect of test conditions. J Antimicrob Chemother (1982) 0.83
Urine ion equilibria. A numerical approach demonstrated by application to antistone therapy. Invest Urol (1969) 0.83
Smoking and longevity. Science (1984) 0.83
Inorganic phosphates in the treatment of renal calculi. Mod Treat (1967) 0.82
Blood loss following cryosurgery of the prostate. J Urol (1968) 0.82
The frequency of metabolic evaluation in "stone patients". South Med J (1967) 0.82
Cloning and characterization of an aminoglycoside 6'-N-acetyltransferase gene from Citrobacter freundii which confers an altered resistance profile. Antimicrob Agents Chemother (1997) 0.81
Structure-activity relationships of tetracyclines. I. Inhibition of cell division and protein and nucleic acid syntheses in Escherichia coli W. J Pharm Sci (1971) 0.81
What's new in the antibiotic pipeline. Curr Opin Microbiol (1999) 0.81
Quantification and prediction of the biological activities of chloramphenicol analogs by microbial kinetics. J Med Chem (1966) 0.81
Aminoglycoside resistance among Danish blood culture isolates of coagulase-negative staphylococci. APMIS (1996) 0.81
Oxanthromicin, a novel antibiotic from Actinomadura. J Antibiot (Tokyo) (1984) 0.80
Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B. Antimicrob Agents Chemother (1987) 0.80
Selective chemical modifications of polymyxin B. Bioorg Med Chem Lett (1998) 0.80
Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp. from two Danish hospitals: correlation with type of aminoglycoside used. APMIS (1996) 0.79
Antibacterial structure-activity relationships obtained with resistant microorganisms I: Inhibition of R-factor resistant Escherichia coli by tetracyclines. J Pharm Sci (1977) 0.79
Is the longevity gender gap decreasing? N Y State J Med (1986) 0.78
Microbiological and pharmacokinetic studies of acyl demycinosyltylosin and related tylosin derivatives. J Antibiot (Tokyo) (1990) 0.77
Post-prostatectomy impotence. J Urol (1976) 0.77
Cryotherapy of benign and neoplastic tumors of the prostate. Surg Gynecol Obstet (1967) 0.77
A novel phenazine antifungal antibiotic, 1,6-dihydroxy-2-chlorophenazine. Fermentation, isolation, structure and biological properties. J Antibiot (Tokyo) (1984) 0.77
Effect of NaCl supplementation of Mueller-Hinton broth on susceptibility of staphylococci to aminoglycosides. Antimicrob Agents Chemother (1986) 0.77
Sch 39304, a new antifungal agent: oral and topical treatment of vaginal and superficial infections. J Med Vet Mycol (1993) 0.76
Evaluation of (+)-cyclaradine-5'-esters as prodrugs for (+)-cyclaradine in animals. Antimicrob Agents Chemother (1987) 0.75
Response to Dr. Waldron's critique of smoking studies. Public Health Rep (1987) 0.75
Chemical modification of some gentamicins and sisomicin at the 3''-position. J Antibiot (Tokyo) (1978) 0.75
Passive smoking-corrections in tables of april article. West J Med (1984) 0.75
Active and passive smoking. Br Med J (Clin Res Ed) (1984) 0.75
Prohibiting psychiatric diagnosis in insanity trials. With special reference to John W. Hinckley, Jr. Psychiatry (1986) 0.75
In vitro and in vivo characterization of novel 8-methoxy derivatives of chlortetracycline. J Antibiot (Tokyo) (1987) 0.75
A penalty method to model particle interactions in DNA-laden flows. J Nanosci Nanotechnol (2008) 0.75
A new class of 2-heterocyclylalkylthiopenems. J Antibiot (Tokyo) (1986) 0.75
A new tetracycline antibiotic from a Dactylosporangium species. Fermentation, isolation and structure elucidation. J Antibiot (Tokyo) (1987) 0.75
Smoking and longevity. Science (1985) 0.75
A novel tetracycline from Actinomadura brunnea. Fermentation, isolation and structure elucidation. J Antibiot (Tokyo) (1987) 0.75
Direct selection of a specifically blocked mutant of Actinomadura brunnea. Isolation of a third 8-methoxy substituted chlortetracycline. J Antibiot (Tokyo) (1987) 0.75
Paleoclimatology: late quaternary environments of the soviet union. Science (1985) 0.75
The "less hazardous" cigarette: a deadly delusion. N Y State J Med (1985) 0.75